Phosphorylated osteopontin peptides suppress crystallization by inhibiting the growth of calcium oxalate crystals
- 1 July 2001
- journal article
- Published by Elsevier in Kidney International
- Vol. 60 (1) , 77-82
- https://doi.org/10.1046/j.1523-1755.2001.00772.x
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Modulation of Osteopontin Post-translational State by 1,25-(OH)2-Vitamin D3Journal of Biological Chemistry, 1998
- Contribution of human uropontin to inhibition of calcium oxalate crystallizationKidney International, 1998
- Quantitative studies of human urinary excretion of uropontinKidney International, 1998
- Posttranslational modifications of bovine osteopontin: Identification of twenty‐eight phosphorylation and three O‐glycosylation sitesProtein Science, 1995
- Modulation of crystal formation by bone phosphoproteins: structural specificity of the osteopontin-mediated inhibition of hydroxyapatite formationBiochemical Journal, 1994
- Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gelBone and Mineral, 1993
- The Pathogenesis and Treatment of Kidney StonesNew England Journal of Medicine, 1992
- Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily.Proceedings of the National Academy of Sciences, 1992
- Osteopontin--a possible anchor of osteoclasts to bone.Proceedings of the National Academy of Sciences, 1990
- Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1987